Page last updated: 2024-08-24

valsartan and Congenitally Corrected Transposition

valsartan has been researched along with Congenitally Corrected Transposition in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fusco, F; Grimaldi, N; Iannuzzi, A; Merola, A; Palma, M; Sarubbi, B; Scognamiglio, G1

Other Studies

1 other study(ies) available for valsartan and Congenitally Corrected Transposition

ArticleYear
Safety and Efficacy of Sacubitril/Valsartan in Patients With a Failing Systemic Right Ventricle: A Prospective Single-Center Study.
    Circulation. Heart failure, 2023, Volume: 16, Issue:2

    Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Congenitally Corrected Transposition of the Great Arteries; Drug Combinations; Female; Heart Failure; Heart Ventricles; Humans; Male; Prospective Studies; Quality of Life; Stroke Volume; Tetrazoles; Transposition of Great Vessels; Valsartan

2023